EP3280445 - GENE THERAPY TO PREVENT REACTIONS TO ALLERGENS [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 15.12.2023 Database last updated on 03.09.2024 | |
Former | Grant of patent is intended Status updated on 03.08.2023 | ||
Former | Examination is in progress Status updated on 15.01.2021 | ||
Former | Request for examination was made Status updated on 12.01.2018 | ||
Former | The international publication has been made Status updated on 10.11.2017 | Most recent event Tooltip | 08.08.2024 | Lapse of the patent in a contracting state New state(s): SE | published on 11.09.2024 [2024/37] | Applicant(s) | For all designated states Cornell University Center for Technology Licensing at Cornell University (CTL) 395 Pine Tree Road, Suite 310 Ithaca, New York 14850 / US | [2023/35] |
Former [2018/07] | For all designated states Cornell University Centre for Technology Licensing at Cornell University (CTL) 395 Pine Tree Road Suite 310 Ithaca, NY 14850 / US | Inventor(s) | 01 /
CRYSTAL, Ronald G. 435 East 70th Street Apt. 34-B New York, New York 10021 / US | 02 /
PAGOVICH, Odelya E. 1330 First Avenue New York, New York 10021 / US | 03 /
CHIUCHIOLO, Maria J. 2501 Porter St NW, Apt 912 Washington, DC 20008 / US | [2018/36] |
Former [2018/07] | 01 /
CRYSTAL, Ronald G. 435 East 70th Street Apt. 34-B New York, New York 10021 / US | ||
02 /
PAGOVICH, Odelya E. 1330 First Avenue New York, New York 10021 / US | |||
03 /
CHIUCHIOLO, Maria J. 450 East 63rd Street Apt. 3B New York, New York 10065 / US | Representative(s) | Maiwald GmbH Elisenhof Elisenstraße 3 80335 München / DE | [2024/03] |
Former [2018/07] | Huenges, Martin Maiwald Patentanwalts GmbH Elisenhof Elisenstrasse 3 80335 München / DE | Application number, filing date | 16777501.4 | 11.04.2016 | [2018/07] | WO2016US26977 | Priority number, date | US201562145035P | 09.04.2015 Original published format: US 201562145035 P | US201662314740P | 29.03.2016 Original published format: US 201662314740 P | [2018/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016164920 | Date: | 13.10.2016 | Language: | EN | [2016/41] | Type: | A1 Application with search report | No.: | EP3280445 | Date: | 14.02.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.10.2016 takes the place of the publication of the European patent application. | [2018/07] | Type: | B1 Patent specification | No.: | EP3280445 | Date: | 17.01.2024 | Language: | EN | [2024/03] | Search report(s) | International search report - published on: | US | 13.10.2016 | (Supplementary) European search report - dispatched on: | EP | 17.04.2019 | Classification | IPC: | A61K39/395, C12N15/00 | [2018/07] | CPC: |
C07K16/4291 (EP,US);
A61K48/0066 (US);
A01K67/0271 (EP,US);
A01K67/0278 (US);
A61K48/0091 (US);
A61P37/08 (EP);
C12N15/8509 (US);
C12N15/86 (EP,US);
A01K2207/12 (EP,US);
A01K2227/105 (EP,US);
A01K2267/0387 (EP,US);
A61K2039/505 (EP,US);
C07K2317/24 (EP,US);
C07K2317/76 (EP,US);
C12N2015/8536 (US);
C12N2750/14143 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/07] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | GENTHERAPIE ZUR VERHINDERUNG VON REAKTIONEN AUF ALLERGENE | [2018/07] | English: | GENE THERAPY TO PREVENT REACTIONS TO ALLERGENS | [2018/07] | French: | THÉRAPIE GÉNIQUE POUR PRÉVENIR LES RÉACTIONS À DES ALLERGÈNES | [2018/07] | Entry into regional phase | 09.11.2017 | National basic fee paid | 09.11.2017 | Search fee paid | 09.11.2017 | Designation fee(s) paid | 09.11.2017 | Examination fee paid | Examination procedure | 09.11.2017 | Examination requested [2018/07] | 09.11.2017 | Date on which the examining division has become responsible | 18.11.2019 | Amendment by applicant (claims and/or description) | 15.01.2021 | Despatch of a communication from the examining division (Time limit: M06) | 19.07.2021 | Reply to a communication from the examining division | 17.05.2022 | Despatch of a communication from the examining division (Time limit: M02) | 27.07.2022 | Reply to a communication from the examining division | 04.08.2023 | Communication of intention to grant the patent | 11.12.2023 | Fee for grant paid | 11.12.2023 | Fee for publishing/printing paid | 11.12.2023 | Receipt of the translation of the claim(s) | Fees paid | Renewal fee | 27.04.2018 | Renewal fee patent year 03 | 29.04.2019 | Renewal fee patent year 04 | 27.04.2020 | Renewal fee patent year 05 | 27.04.2021 | Renewal fee patent year 06 | 27.04.2022 | Renewal fee patent year 07 | 27.04.2023 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 17.01.2024 | BG | 17.01.2024 | ES | 17.01.2024 | FI | 17.01.2024 | HR | 17.01.2024 | LT | 17.01.2024 | LV | 17.01.2024 | NL | 17.01.2024 | PL | 17.01.2024 | SE | 17.01.2024 | NO | 17.04.2024 | RS | 17.04.2024 | GR | 18.04.2024 | IS | 17.05.2024 | PT | 17.05.2024 | [2024/37] |
Former [2024/36] | AT | 17.01.2024 | |
BG | 17.01.2024 | ||
ES | 17.01.2024 | ||
FI | 17.01.2024 | ||
HR | 17.01.2024 | ||
LT | 17.01.2024 | ||
LV | 17.01.2024 | ||
NL | 17.01.2024 | ||
PL | 17.01.2024 | ||
NO | 17.04.2024 | ||
RS | 17.04.2024 | ||
GR | 18.04.2024 | ||
IS | 17.05.2024 | ||
PT | 17.05.2024 | ||
Former [2024/35] | AT | 17.01.2024 | |
BG | 17.01.2024 | ||
ES | 17.01.2024 | ||
FI | 17.01.2024 | ||
HR | 17.01.2024 | ||
LT | 17.01.2024 | ||
NL | 17.01.2024 | ||
NO | 17.04.2024 | ||
RS | 17.04.2024 | ||
GR | 18.04.2024 | ||
IS | 17.05.2024 | ||
Former [2024/34] | BG | 17.01.2024 | |
FI | 17.01.2024 | ||
HR | 17.01.2024 | ||
LT | 17.01.2024 | ||
NL | 17.01.2024 | ||
NO | 17.04.2024 | ||
RS | 17.04.2024 | ||
GR | 18.04.2024 | ||
IS | 17.05.2024 | ||
Former [2024/33] | LT | 17.01.2024 | |
NL | 17.01.2024 | ||
NO | 17.04.2024 | ||
IS | 17.05.2024 | ||
Former [2024/32] | NL | 17.01.2024 | |
IS | 17.05.2024 | ||
Former [2024/31] | NL | 17.01.2024 | Documents cited: | Search | [XYI]WO9901556 (GENENTECH INC [US]) [X] 1-3,5,8,9 * see whole document and in particular paragraph "B. Vectors, Host Cells and recombinant methods" pages 44-49 and Examples 2 and 4.;; sequences 3, 6, 13 * [Y] 6-8 [I] 4,10-14; | [Y] - "Mus musculus anti-IgE F(ab)-2 variable heavy chain.", Geneseq, (19990608), Database accession no. AAW95648, URL: EBI, XP002787428 [Y] 6-8 * the whole document * | [Y] - "Mus musculus anti-IgE F(ab)-2 variable light chain.", Geneseq, (19990608), Database accession no. AAW95651, URL: EBI, XP002787429 [Y] 6-8 * the whole document * | [Y] - "Mus musculus anti-IgE e25 full length variable light chain.", Geneseq, (19990608), Database accession no. AAW95658, URL: EBI, XP002787430 [Y] 6-8 * the whole document * | [Y] - CARTON ET AL, "Codon engineering for improved antibody expression in mammalian cells", PROTEIN EXPRESSION AND PURIFICATION, ACADEMIC PRESS, SAN DIEGO, CA, (20070908), vol. 55, no. 2, doi:10.1016/J.PEP.2007.05.017, ISSN 1046-5928, pages 279 - 286, XP022238133 [Y] 6-8 * the whole document * DOI: http://dx.doi.org/10.1016/j.pep.2007.05.017 | International search | [A]US2004229310 (SIMMONS LAURA [US]) [A] 11, 12, (16-19)/(11,12) * para [0044]-[0045] and SEQ ID NOs: 20, 22. *; | [XY]US2010113361 (MORSEY MOHAMAD A [US], et al) [X] 1-3, 7-9, (16-19)/(1-3,7-9) * para [0024]; [0031]; [0071]; [0077]; [0086]-[0090]; [0097]; [0100] [0104]; [0130]-[0135]; [0146]; [0147]. * [Y] 4-6, 10, (16-19)/(4-6,10-15); | [A]US2010136030 (SALAH-EDDINE LAMHAMEDI-CHERRADI [US], et al) [A] 11,12,(16-19)/(11,12) * para [0021] and SEQ ID NO: 22. *; | [A]US2010143262 (VALENTA RUDOLPH [AT], et al) [A] 1* abstract. *; | [A]US2010189729 (HOERR INGMAR [DE], et al) [A] 13, (16-19)/13 * para [0046] and SEQ ID NOs: 15 and 53. *; | [XYA]US2011064726 (LIU WAI [GB], et al) [X] 1,14,15 * para [0006]; [0004]; [0114]; [0174]; [0374]; [0413]. * [Y] (16-19)/(14,15) [A] 11-13, (16-19)/(11-13); | [Y]US2011065779 (FANG JIANMIN [US], et al) [Y] 10,(16-19)/10 * para [0013]; [0123]-[0125]. *; | [A]US2012258107 (GRAVERSEN NIELS JONAS HEILSKOV [DK], et al) [A] 11,12, (16-19)/(11,12) * para [0588]; SEQ ID NO: 81. *; | [A]US2013058936 (BRUENKER PETER [CH], et al) [A] 11,12,(16-19)/(11,12) * para [0220] and SEQ ID NO: 45 *; | [A]US2013236467 (GRIGGS JEREMY [GB], et al) [A] 11,12,(16-19)/(11,12) * Table 5 and SEQ ID NO: 99. *; | [Y]US2014336245 (MINGOZZI FEDERICO [FR], et al) [Y] 4-6 and (16-19)/(4-6) * para [0011]-[0018]. * | by applicant | US4797368 | US4863457 | US5378475 | US5443505 | US5464758 | US5814618 | WO9901556 | US6342390 | US6682735 | US6723551 | US6821511 | US7112715 | US2011064726 | - IM et al., Cell,, (19900000), vol. 61, pages 447 - 57 | - CHIORINI et al., J. Virol., (19970000), vol. 71, pages 6823 - 1088 | - CEARLEY et al., Molecular Therapy, (20060000), vol. 13, no. 3, pages 528 - 537 | - CARTER, B.J., Hum. Gene Ther., (20050000), vol. 16, pages 541 - 550 | - SRIVASTAVA et al., J. Virol., (19830000), vol. 45, pages 555 - 64 | - BANTEL-SCHAAL et al., J. Virol., (19990000), vol. 73, no. 2, pages 1309 - 1319 | - RUTLEDGE et al., J. Virol., (19980000), vol. 72, pages 309 - 319 | - WU et al., J. Virol., (20000000), vol. 74, pages 8635 - 47 | - DE et al., Mol. Ther., (20060000), vol. 13, no. 1, pages 77 - 87 | - GAO et al., J. Virol., (20040000), vol. 78, pages 6381 - 6388 | - GAO et al., Proc. Natl. Acad. Sci. USA, (20020000), vol. 99, pages 11854 - 11859 | - WATANABE et al., Gene Ther., (20100000), vol. 77, no. 8, pages 1042 - 1051 | - MAO et al., Hum. Gene Therapy, (20110000), vol. 22, pages 1525 - 1535 | - NO et al., Proc. Natl. Acad. Sci., (19960000), vol. 93, pages 3346 - 3351 | - INDRA et al., Nuc. Acid. Res., (19990000), vol. 27, pages 4324 - 4327 | - KRAMERFUSSENEGGER, Methods Mol. Biol., (20050000), vol. 308, pages 123 - 144 | - HOLLIGER et al., Nat. Biotech., (20050000), vol. 23, no. 9, pages 1126 - 1129 | - KOHLERMILSTEIN, Eur. J. Immunol., (19760000), vol. 5, pages 511 - 519 | - LONBERG, Nat. Biotechnol., (20050000), vol. 23, no. 9, pages 1117 - 25 | - LONBERG, Handb. Exp. Pharmacol., (20080000), vol. 181, pages 69 - 97 | - "Gene Expression Technology", GOEDDEL, Methods in Enzymology, Academic Press, San Diego, (19900000), vol. 185 | - NIWA et al., Gene, (19910000), vol. 108, pages 193 - 199 | - DALY et al., Proc. Natl. Acad. Sci. U.S.A., (19990000), vol. 96, pages 2296 - 2300 | - SONDHI et al., Mo/. Ther., (20070000), vol. 15, pages 481 - 491 | - WRIGHT et al., Curr. Opin. Drug Discov. Devel., (20030000), vol. 6, no. 2, pages 174 - 178 | - WRIGHT et al., Molecular Therapy, (20050000), vol. 12, pages 171 - 178 |